[House Report 114-560]
[From the U.S. Government Publishing Office]
114th Congress } { Report
HOUSE OF REPRESENTATIVES
2d Session } { 114-560
======================================================================
EXAMINING OPIOID TREATMENT INFRASTRUCTURE ACT OF 2016
_______
May 10, 2016.--Committed to the Committee of the Whole House on the
State of the Union and ordered to be printed
_______
Mr. Upton, from the Committee on Energy and Commerce, submitted the
following
R E P O R T
[To accompany H.R. 4982]
[Including cost estimate of the Congressional Budget Office]
The Committee on Energy and Commerce, to whom was referred
the bill (H.R. 4982) to direct the Comptroller General of the
United States to evaluate and report on the in-patient and
outpatient treatment capacity, availability, and needs of the
United States, having considered the same, report favorably
thereon with an amendment and recommend that the bill as
amended do pass.
CONTENTS
Page
Purpose and Summary.............................................. 2
Background and Need for Legislation.............................. 2
Hearings......................................................... 2
Committee Consideration.......................................... 2
Committee Votes.................................................. 3
Committee Oversight Findings..................................... 3
Statement of General Performance Goals and Objectives............ 3
New Budget Authority, Entitlement Authority, and Tax Expenditures 3
Earmark, Limited Tax Benefits, and Limited Tariff Benefits....... 3
Committee Cost Estimate.......................................... 3
Congressional Budget Office Estimate............................. 3
Federal Mandates Statement....................................... 4
Duplication of Federal Programs.................................. 4
Disclosure of Directed Rule Makings.............................. 4
Advisory Committee Statement..................................... 4
Applicability to Legislative Branch.............................. 5
Section-by-Section Analysis of the Legislation................... 5
Changes in Existing Law Made by the Bill, as Reported............ 5
The amendment is as follows:
Strike all after the enacting clause and insert the
following:
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Examining Opioid Treatment
Infrastructure Act of 2016''.
SEC. 2. STUDY ON TREATMENT INFRASTRUCTURE.
Not later than 24 months after the date of enactment of this Act, the
Comptroller General of the United States shall initiate an evaluation,
and submit to Congress a report, of the inpatient and outpatient
treatment capacity, availability, and needs of the United States, which
shall include, to the extent data are available--
(1) the capacity of acute residential or inpatient
detoxification programs;
(2) the capacity of inpatient clinical stabilization
programs, transitional residential support services, and
residential rehabilitation programs;
(3) the capacity of demographic specific residential or
inpatient treatment programs, such as those designed for
pregnant women or adolescents;
(4) geographical differences of the availability of
residential and outpatient treatment and recovery options for
substance use disorders across the continuum of care;
(5) the availability of residential and outpatient treatment
programs that offer treatment options based on reliable
scientific evidence of efficacy for the treatment of substance
use disorders, including the use of Food and Drug
Administration-approved medicines and evidence-based
nonpharmacological therapies;
(6) the number of patients in residential and specialty
outpatient treatment services for substance use disorders;
(7) an assessment of the need for residential and outpatient
treatment for substance use disorders across the continuum of
care;
(8) the availability of residential and outpatient treatment
programs to American Indians and Alaska Natives through an
Indian health program (as defined by section 4 of the Indian
Health Care Improvement Act (25 U.S.C. 1603)); and
(9) the barriers (including technological barriers) at the
Federal, State, and local levels to real-time reporting of de-
identified information on drug overdoses and ways to overcome
such barriers.
PURPOSE AND SUMMARY
H.R. 4982, the ``Examining Opioid Treatment Infrastructure
Act of 2016'' was introduced by Rep. Foster (D-IL) on April 18,
2016. The bill directs the Government Accountability Office
(GAO) to evaluate and report on the in-patient and outpatient
treatment capacity, availability, and needs of the United
States.
BACKGROUND AND NEED FOR LEGISLATION
Opiate-related overdoses have become a significant cause of
injury related to death nationwide. This bill directs GAO to
issue a report that will provide important information related
to treatment capacity, availability, and needs throughout the
United States.
HEARINGS
The Committee on Energy and Commerce has not held hearings
on the legislation.
COMMITTEE CONSIDERATION
On April 20, 2016, the Subcommittee on Health met in open
markup session and forwarded a discussion draft entitled the
``Examining Opioid Treatment Infrastructure Act of 2016'' to
the full Committee, without amendment, by a voice vote. The
discussion draft was identical to H.R. 4982. On April 26, 27,
and 28, 2016, the full Committee on Energy and Commerce met in
open markup session and ordered H.R. 4982 reported to the
House, as amended, by a voice vote.
COMMITTEE VOTES
Clause 3(b) of rule XIII of the rules of the House of
Representatives requires the Committee to list the record votes
on the motion to report legislation and amendments thereto.
There were no record votes taken in connection with ordering
H.R. 4982 reported.
COMMITTEE OVERSIGHT FINDINGS
Pursuant to clause 3(c)(1) of Rule XIII of the Rules of the
House of Representatives, the Committee did not hold a hearing
on this legislation.
STATEMENT OF GENERAL PERFORMANCE GOALS AND OBJECTIVES
The goal of the legislation is to examine in-patient and
outpatient opioid treatment capacities.
NEW BUDGET AUTHORITY, ENTITLEMENT AUTHORITY, AND TAX EXPENDITURES
In compliance with clause 3(c)(2) of rule XIII of the Rules
of the House of Representatives, the Committee finds that H.R.
4982 would result in no new or increased budget authority,
entitlement authority, or tax expenditures or revenues.
EARMARK, LIMITED TAX BENEFITS, AND LIMITED TARIFF BENEFITS
In compliance with clause 9(e), 9(f), and 9(g) of rule XXI
of the Rules of the House of Representatives, the Committee
finds that H.R. 4982 contains no earmarks, limited tax
benefits, or limited tariff benefits.
COMMITTEE COST ESTIMATE
The Committee adopts as its own the cost estimate prepared
by the Director of the Congressional Budget Office pursuant to
section 402 of the Congressional Budget Act of 1974.
CONGRESSIONAL BUDGET OFFICE ESTIMATE
Pursuant to clause 3(c)(3) of rule XIII of the Rules of the
House of Representatives, the following is the cost estimate
provided by the Congressional Budget Office pursuant to section
402 of the Congressional Budget Act of 1974:
U.S. Congress,
Congressional Budget Office,
Washington, DC, May 9, 2016.
Hon. Fred Upton,
Chairman, Committee on Energy and Commerce,
House of Representatives, Washington, DC.
Dear Mr. Chairman: The Congressional Budget Office has
prepared the enclosed cost estimate for H.R. 4982, the
Examining Opioid Treatment Infrastructure Act of 2016.
If you wish further details on this estimate, we will be
pleased to provide them. The CBO staff contact is Zoe Williams.
Sincerely,
Keith Hall.
Enclosure.
H.R. 4982--Examining Opioid Treatment Infrastructure Act of 2016
H.R. 4982 would direct the Government Accountability Office
(GAO) to conduct an evaluation of the infrastructure for
treating opioid and other substance abuse in the United States.
The bill would require GAO to submit a report to the Congress
on the evaluation no later than 24 months after the date of
enactment.
The evaluation would assess the capacity of detoxification
and stabilization programs, transitional residential support
services, residential rehabilitation programs, and demographic-
specific treatment programs. The evaluation also would measure
any geographical differences in the treatment infrastructure
and the need for residential and outpatient treatment for
substance use disorders. GAO's report would include an
assessment of the availability of certain treatment programs
and detail any barriers to real-time reporting of information
on drug overdoses.
CBO estimates that implementing H.R. 4982 would cost less
than $500,000 over the 2017-2021 period; any such spending
would be subject to the availability of appropriated funds.
Pay-as-you-go procedures do not apply to this legislation
because it would not affect direct spending or revenues.
CBO estimates that enacting H.R. 4982 would not increase
direct spending or on-budget deficits in any of the four
consecutive 10-year periods beginning in 2027.
H.R. 4982 contains no intergovernmental or private-sector
mandates as defined in the Unfunded Mandates Reform Act and
would impose no costs on state, local, or tribal governments.
The CBO staff contact for this estimate is Zoe Williams.
The estimate was approved by Holly Harvey, Deputy Assistant
Director for Budget Analysis.
FEDERAL MANDATES STATEMENT
The Committee adopts as its own the estimate of Federal
mandates prepared by the Director of the Congressional Budget
Office pursuant to section 423 of the Unfunded Mandates Reform
Act.
DUPLICATION OF FEDERAL PROGRAMS
No provision of H.R. 4982 establishes or reauthorizes a
program of the Federal Government known to be duplicative of
another Federal program, a program that was included in any
report from the Government Accountability Office to Congress
pursuant to section 21 of Public Law 111-139, or a program
related to a program identified in the most recent Catalog of
Federal Domestic Assistance.
DISCLOSURE OF DIRECTED RULE MAKINGS
The Committee estimates that enacting H.R. 4982
specifically directs to be completed 0 rule makings within the
meaning of 5 U.S.C. 551.
ADVISORY COMMITTEE STATEMENT
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
APPLICABILITY TO LEGISLATIVE BRANCH
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
SECTION-BY-SECTION ANALYSIS OF THE LEGISLATION
Section 1. Short title
Section 1 states that the legislation may be cited as the
``Examining Opioid Treatment Infrastructure Act of 2016''
Section 2. Study on treatment infrastructure
Within 24 months of enactment of the legislation, the
Comptroller General of the United States shall initiate an
evaluation and submit to Congress a report on opioid abuse
disorder treatment services including:
(1) the capacity of acute residential or inpatient
detoxification programs;
(2) the capacity of inpatient clinical stabilization
programs, transitional residential support services, and
residential rehabilitation programs;
(3) the capacity of demographic specific residential or
inpatient treatment programs, such as those designed for
pregnant women or adolescents;
(4) geographical differences of the availability of
residential and outpatient treatment and recovery options for
substance use disorders across the continuum of care;
(5) the availability of residential and outpatient
treatment programs that offer treatment options based on
reliable scientific evidence of efficacy for the treatment of
substance use disorders, including the use of Food and Drug
Administration-approved medicines and evidence-based
nonpharmacological therapies;
(6) the number of patients in residential and specialty
outpatient treatment services for substance use disorders;
(7) an assessment of the need for residential and
outpatient treatment for substance use disorders across the
continuum of care;
(8) an examination of the barriers of real time reporting
of de-identified information on drug overdoses; and
(9) an examination of the availability of residential and
outpatient treatment programs within the Indian Health Service
program.
CHANGES IN EXISTING LAW MADE BY THE BILL, AS REPORTED
This legislation does not amend any existing Federal
statute.
[all]